Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health on 29 May
Alfasigma inaugurates the new Research and Development center in Pomezia named after its founder Marino Golinelli
Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit
Alfasigma acquires Lumeblue™ (Methylene Blue MMX) rights for EU distribution, consolidating its Gastro-Intestinal portfolio
Alfasigma to expand its digital footprint
Alfasigma launches its first full digital hackathon - Alfathon
COVID-19 outbreak: Alfasigma donates over 100.000 euros to Romanian Hospitals
Alfasigma joins the global fight against COVID-19 participating to GEFACOVID Project
Coronavirus, italian pharmaceutical companies donate 3 million Euros
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulc...